ScholarLens Back to search
2014•PubMedRequires access

Glycopyrronium + indacaterol. A fixed-dose combination with no advantages in COPD.

Author information unavailable

Open publisher page 0 citations

Abstract

No more effective than tiotropium combined with formoterol.

About this research paper

What this paper is about

No more effective than tiotropium combined with formoterol.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

No more effective than tiotropium combined with formoterol.

Key concepts: Indacaterol, Fixed-dose combination, COPD, Medicine, Pharmacology, Internal medicine, Asthma, Bronchodilator

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Glycopyrronium + indacaterol. A fixed-dose combination with no advantages in COPD. — Research Paper | ScholarLens